A Practical Approach to Managing Cardiovascular-Kidney-Metabolic Syndrome

Matching Interventions to the Risk

Cardiovascular-kidney-metabolic (CKM) syndrome is an emerging and critical health concern due to its high prevalence and association with chronic kidney disease (CKD) and cardiovascular events. In this webinar, we’ll focus on identifying individuals at high risk for CKD by utilizing estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) testing to achieve accurate risk stratification.

You’ll learn how to employ risk stratification techniques, including CKD heatmaps, to predict kidney and cardiovascular outcomes. This approach facilitates targeted patient education and guides individualized interventions for kidney and cardioprotection. We’ll also define essential roles within primary care and nephrology and highlight practical strategies for implementing CKM-focused screening and management in routine practice.

Learning Objectives

This webinar will help you:

• Detect and risk-stratify CKD with eGFR and ACR testing
• Assess kidney and cardiovascular risk using heatmaps and prediction equations
• Evaluate patient education and guide kidney and cardioprotective interventions
• Integrate CKM-focused screening and management into routine practice

Watch on Demand       Download Slides (PDF, 4.6 MB)

Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.

Joseph A. Vassalotti, MD

Dr. Vassalottii has led collaborations to develop the Kidney Health Evaluation for Adults with Diabetes quality measure to improve evidence-based CKD testing with eGFR and albuminuria and guide detection, risk stratification, and interventions proportional to risk. He has served as principal investigator for an AARP-funded Quality Measures Innovation Grant to analyze CKD testing interactions with detection, evidence-based interventions, and health equity. He is also a co-investigator for the Centers for Disease Control and Prevention's (CDC) CKD Surveillance Project. Dr. Vassalotti’s major academic interests are primary care and population health for CKD. He sees approximately 40 patients weekly and has authored over 100 publications in peer-reviewed journals.